Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study - 20/08/13
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Summary |
Background |
Middle East respiratory syndrome (MERS) is a new human disease caused by a novel coronavirus (CoV). Clinical data on MERS-CoV infections are scarce. We report epidemiological, demographic, clinical, and laboratory characteristics of 47 cases of MERS-CoV infections, identify knowledge gaps, and define research priorities.
Methods |
We abstracted and analysed epidemiological, demographic, clinical, and laboratory data from confirmed cases of sporadic, household, community, and health-care-associated MERS-CoV infections reported from Saudi Arabia between Sept 1, 2012, and June 15, 2013. Cases were confirmed as having MERS-CoV by real-time RT-PCR.
Findings |
47 individuals (46 adults, one child) with laboratory-confirmed MERS-CoV disease were identified; 36 (77%) were male (male:female ratio 3·3:1). 28 patients died, a 60% case-fatality rate. The case-fatality rate rose with increasing age. Only two of the 47 cases were previously healthy; most patients (45 [96%]) had underlying comorbid medical disorders, including diabetes (32 [68%]), hypertension (16 [34%]), chronic cardiac disease (13 [28%]), and chronic renal disease (23 [49%]). Common symptoms at presentation were fever (46 [98%]), fever with chills or rigors (41 [87%]), cough (39 [83%]), shortness of breath (34 [72%]), and myalgia (15 [32%]). Gastrointestinal symptoms were also frequent, including diarrhoea (12 [26%]), vomiting (ten [21%]), and abdominal pain (eight [17%]). All patients had abnormal findings on chest radiography, ranging from subtle to extensive unilateral and bilateral abnormalities. Laboratory analyses showed raised concentrations of lactate dehydrogenase (23 [49%]) and aspartate aminotransferase (seven [15%]) and thrombocytopenia (17 [36%]) and lymphopenia (16 [34%]).
Interpretation |
Disease caused by MERS-CoV presents with a wide range of clinical manifestations and is associated with substantial mortality in admitted patients who have medical comorbidities. Major gaps in our knowledge of the epidemiology, community prevalence, and clinical spectrum of infection and disease need urgent definition.
Funding |
None.
Le texte complet de cet article est disponible en PDF.Plan
Vol 13 - N° 9
P. 752-761 - septembre 2013 Retour au numéro
Article précédent
- Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection
- Christian Drosten, Michael Seilmaier, Victor M Corman, Wulf Hartmann, Gregor Scheible, Stefan Sack, Wolfgang Guggemos, Rene Kallies, Doreen Muth, Sandra Junglen, Marcel A Müller, Walter Haas, Hana Guberina, Tim Röhnisch, Monika Schmid-Wendtner, Souhaib Aldabbagh, Ulf Dittmer, Hermann Gold, Petra Graf, Frank Bonin, Andrew Rambaut, Clemens-Martin Wendtner
- Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007–2011
- Catherine A Ison, Katy Town, Chinelo Obi, Stephanie Chisholm, Gwenda Hughes, David M Livermore, Catherine M Lowndes, on behalf of the GRASP collaborative group †
Bienvenue sur EM-consulte, la référence des professionnels de santé.